Showing results (31-40 of 52) with videos related to

Sort By:
Pageof 6
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|June 13, 2021
The correlation of the serum level of L-carnitine with disease severity in patients with Amyotrophic lateral sclerosisPayam Sarraf, Sama Bitarafan, Shahriar Nafissi, et al.
Neuropathology : Official Journal of the Japanese Society of Neuropathology|June 26, 2024
Phenotypic and genotyping spectrum of two Iranian cases with RBCK1-associated polyglucosan body myopathyMarzieh Babaee, Yalda Nilipour, Sahar Alijanpour, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|February 15, 2019
The Neuromodulatory Effects of ω-3 Fatty Acids and Nano-Curcumin on the COX-2/ iNOS Network in Migraines: A Clinical Trial Study from Gene Expression to Clinical SymptomsMina Abdolahi, Arash Jafarieh, Payam Sarraf, et al.
Muscle & Nerve|November 28, 2025
A Cohort of Iranian Patients With Congenital Myasthenic Syndrome due to Glycosylation DefectsMahtab Ramezani, Ali Asghar Okhovat, Yalda Nilipour, et al.
Nutritional Neuroscience|May 19, 2020
Effect of probiotic supplementation on migraine prophylaxis: a systematic review and meta-analysis of randomized controlled trialsMohammad Parohan, Mahmoud Djalali, Payam Sarraf, et al.
Current Journal of Neurology|October 21, 2024
Isaacs' syndrome: Clinical and paraclinical perspectives in a series of casesPayam Sarraf, Mahan Shafie, Ghasem Farahmand, et al.
Archives of Iranian Medicine|February 7, 2022
Iranian Consensus Recommendations for Treatment of Myasthenia GravisShahriar Nafissi, Ali Asghar Okhovat, Farnaz Sinaei, et al.
Iranian Journal of Neurology|May 9, 2018
Molecular mechanisms of omega-3 fatty acids in the migraine headacheNeda Soveyd, Mina Abdolahi, Sama Bitarafan, et al.
Frontiers in Neurology|September 13, 2021
Zytux in Refractory Myasthenia Gravis: A Multicenter, Open-Labeled, Clinical Trial Study of Effectiveness and Safety of a Rituximab BiosimilarFarzad Fatehi, Kamyar Moradi, Ali Asghar Okhovat, et al.
CNS & Neurological Disorders Drug Targets|June 26, 2018
A Novel Combination of ω-3 Fatty Acids and Nano-Curcumin Modulates Interleukin-6 Gene Expression and High Sensitivity C-reactive Protein Serum Levels in Patients with Migraine: A Randomized Clinical Trial StudyMina Abdolahi, Payam Sarraf, Mohammad Hassan Javanbakht, et al.
Pageof 6